Iovanace Biotherapeutics (IOVA) PT Lowered to $5 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Price: $8.02 -5.42%
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $5.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Iovanace Biotherapeutics (IOVA) PT Lowered to $9 at Baird
- Church & Dwight Co. Inc. (CHD) PT Raised to $115 at TD Cowen
- Lattice Semiconductor (LSCC) PT Raised to $175 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
